On today's podcast: Oncimmune Reports Substantial Growth in their Interim Results & Alan Green on 3 Companies
Dr Adam M Hill, CEO of Oncimmune #ONC discusses the highlights from their interim results in which they report, substantial revenue growth with increased commercial activity across the business.
Oncimmune is a leading immunodiagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Oncimmune has a diversified and growing revenue from its portfolio of diagnostic products to detect early-stage cancer and a contract discovery and development service-based platform, delivering actionable insights into therapies to its pharmaceutical and biotech partners.
Alan Green, CEO of Brand Communications talks about:
(Interview starts 12 minutes 40 seconds)